CD366 (TIM3) Antibody 14-5870-82 from Thermo Fisher Scientific

81 Wyman Street

Waltham, MA 02451

United States

Phone: 800-678-5599
Fax: 800-331-2286

(2) Oncolytic virus M1 functions as a bifunctional checkpoint inhibitor to enhance the antitumor activity of DC vaccineCell reports. MedicineOctober 17, 2023Dan J, Cai J, Zhong Y, Wang C, Huang S, Zeng Y, Fan Z, Xu C, Hu L, Zhang J, et al.

(3) Sequence-based drug design as a concept in computational drug designNature communicationsJuly 14, 2023Chen L, Fan Z, Chang J, Yang R, Hou H, Guo H, Zhang Y, Yang T, Zhou C, Sui Q, et al.

(4) Extracellular acidosis restricts one-carbon metabolism and preserves T cell stemnessNature metabolismFebruary 1, 2023Cheng H, Qiu Y, Xu Y, Chen L, Ma K, Tao M, Frankiw L, Yin H, Xie E, Pan X, et al.

(5) TIM3 Expression in Anaplastic-Thyroid-Cancer-Infiltrating Macrophages: An Emerging Immunotherapeutic TargetBiologyNovember 3, 2022Palacios LM, Peyret V, Viano ME, Geysels RC, Chocobar YA, Volpini X, Pellizas CG, Nicola JP, Motran CC, Rodriguez-Galan MC, et al.

(6) Mobilizing phospholipids on tumor plasma membrane implicates phosphatidylserine externalization blockade for cancer immunotherapyCell reportsNovember 1, 2022Wang W, Wu S, Cen Z, Zhang Y, Chen Y, Huang Y, Cillo AR, Prokopec JS, Quarato G, Vignali DAA, et al.

(8) Functional assessment of the cell-autonomous role of NADase CD38 in regulating CD8(+) T cell exhaustioniScienceMay 20, 2022Ma K, Sun L, Shen M, Zhang X, Xiao Z, Wang J, Liu X, Jiang K, Xiao-Feng Qin F, Guo F, et al.

(9) PTENα functions as an immune suppressor and promotes immune resistance in PTEN-mutant cancerNature communicationsAugust 26, 2021Sun Y, Lu D, Yin Y, Song J, Liu Y, Hao W, Qi F, Zhang G, Zhang X, Liu L, et al.

(10) Type 1 Cytotoxic T Cells Increase in Placenta after Intrauterine InflammationFrontiers in immunologyJanuary 1, 2021Liu J, Liu Y, Panda S, Liu A, Lei J, Burd I.

(11) A Fas-4-1BB fusion protein converts a death to a pro-survival signal and enhances T cell therapyThe Journal of experimental medicineDecember 7, 2020Oda SK, Anderson KG, Ravikumar P, Bonson P, Garcia NM, Jenkins CM, Zhuang S, Daman AW, Chiu EY, Bates BM, et al.

(12) Inhibition of the Wnt/β-catenin pathway enhances antitumor immunity in ovarian cancerTherapeutic advances in medical oncologyJanuary 1, 2020Doo DW, Meza-Perez S, Londoño AI, Goldsberry WN, Katre AA, Boone JD, Moore DJ, Hudson CT, Betella I, McCaw TR, et al.

(13) Mapping the Lineage Relationship between CXCR5⁺ and CXCR5^- CD4⁺ T Cells in HIV-Infected Human Lymph NodesCell reportsSeptember 17, 2019Del Alcazar D, Wang Y, He C, Wendel BS, Del Río-Estrada PM, Lin J, Ablanedo-Terrazas Y, Malone MJ, Hernandez SM, Frank I, et al.

(14) Mechanisms of action of ruxolitinib in murine models of hemophagocytic lymphohistiocytosisBloodJuly 11, 2019Albeituni S, Verbist KC, Tedrick PE, Tillman H, Picarsic J, Bassett R, Nichols KE.

(17) Growth and metastasis of lung adenocarcinoma is potentiated by BMP4-mediated immunosuppressionOncoimmunologyJanuary 1, 2016Chen L, Yi X, Goswami S, Ahn YH, Roybal JD, Yang Y, Diao L, Peng D, Peng D, Fradette JJ, et al.

(19) Combined immune checkpoint protein blockade and low dose whole body irradiation as immunotherapy for myelomaJournal for immunotherapy of cancerJanuary 1, 2015Jing W, Gershan JA, Weber J, Tlomak D, McOlash L, Sabatos-Peyton C, Johnson BD.

(20) Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppressionNature communicationsOctober 28, 2014Chen L, Gibbons DL, Goswami S, Cortez MA, Ahn YH, Byers LA, Zhang X, Yi X, Dwyer D, Lin W, et al.

CD366 (TIM3) Antibody from Thermo Fisher Scientific